Leo Lopez
Leo brings over 20 years of experience in corporate strategy and executive leadership, driving Ausphex’s transformation into a pharmaceutical manufacturer, with a focus on innovation, commercialisation and strategic growth.
An Australian pharmaceutical company dedicated to research, development and manufacturing - combining scientific expertise with manufacturing capability to support the next generation of medicines.
To advance pharmaceutical science through research, formulation development and quality-driven manufacturing - improving how medicines are delivered.
To be a recognised leader in drug-delivery technology, contributing to the future of modern medicine.
Meaningful progress starts with sound science. We bring together pharmaceutical research, formulation development and manufacturing expertise to explore new possibilities in drug delivery - and translate them into solutions with real-world application.
Our team brings together expertise across pharmaceutical science, manufacturing, clinical development, quality and regulatory compliance, and business leadership.
Leo brings over 20 years of experience in corporate strategy and executive leadership, driving Ausphex’s transformation into a pharmaceutical manufacturer, with a focus on innovation, commercialisation and strategic growth.
Shan leads Ausphex’s scientific direction, bringing over 30 years of experience in pharmaceutical drug design, formulation and manufacturing. His expertise in drug-delivery technologies and medical innovation drives the development of novel pharmaceutical solutions.
Dharini is an experienced Regulatory Affairs and Quality professional with more than 20 years of experience across the pharmaceutical, medical device, animal health, and healthcare sectors. Specialising in regulatory compliance, quality management systems, GMP, and global regulatory requirements.
Mikayla is a qualified pharmacist with experience across hospital and community pharmacy, bringing a strong clinical foundation to the pharmaceutical industry. She specialises in clinical strategy and healthcare partnerships, with a focus on advancing pharmaceutical innovation and improving patient outcomes.